SPOK HOLDINGS INC (SPOK)

Sector: Communication

    Home/Companies/SPOK/Annual Meeting

2026 Annual Meeting Analysis

SPOK HOLDINGS INC · Meeting: July 21, 2026

Policy v1.2high confidenceView Filing ↗
For informational purposes only. This AI-generated analysis applies a published voting policy to publicly available proxy filings. It does not constitute investment advice, proxy voting advice, or a solicitation of any kind. AI analysis may be incomplete or inaccurate — always review the actual filing and make your own independent decision.

Directors FOR

6

Directors AGAINST

0

Say on Pay

FOR

Auditor

FOR

Director Elections

Election of Six Directors

6 FOR
✓ FOR
Dr. Bobbie Byrne

Director since 2020 with relevant healthcare IT expertise; all attendance requirements met; no overboarding; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold for a low-positive return period.

✓ FOR
Christine M. Cournoyer

Independent Chair since 2020 with relevant technology and executive leadership background; all attendance requirements met; no overboarding; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold.

✓ FOR
Randy H. Hyun

Director since 2021 with healthcare investment and operational expertise; all attendance requirements met; no overboarding; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold.

✓ FOR
Vincent D. Kelly

CEO and director since 2004; not independent but sits on no board committees as an executive director; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold; Say on Pay analysis separately passes policy screens.

✓ FOR
Todd Stein

Director since 2018 with investment and financial expertise; serves as Audit Committee chair and is designated the audit financial expert; all attendance requirements met; no overboarding; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold.

✓ FOR
Brett Shockley

Director since 2020 with technology and AI leadership experience; all attendance requirements met; no overboarding; 3-year TSR outperforms XLV by +2.5pp, well below the 50pp trigger threshold.

All six director nominees pass every policy screen: no overboarding, attendance above 75% threshold for all directors, no familial relationships with senior management, appropriate committee independence, and Spok's 3-year total shareholder return of +16.8% outperforms the XLV sector ETF benchmark by +2.5 percentage points — far below the 50pp underperformance threshold required to trigger a vote against under the low-positive TSR band. A FOR vote is warranted for the full slate.

Say on Pay

✓ FOR

CEO

Vincent D. Kelly

Total Comp

$2,408,910

Prior Support

96%%

CEO Vincent Kelly received total compensation of $2,408,910 in 2025, which is reasonable for a CEO of a ~$222M market-cap healthcare technology company; the independent compensation consultant AON confirmed pay levels are at or below peer group median. The pay program is well-structured: roughly 79% of CEO total compensation is variable (cash bonus plus equity awards), well above the 50-60% policy threshold, and incentive plans use measurable multi-year financial metrics including adjusted EBITDA over a three-year period. Prior year Say on Pay received 96% shareholder support with no negative feedback from stockholder outreach, and the company maintains a meaningful clawback policy and prohibitions on hedging and pledging — all positive governance indicators.

Auditor Ratification

✓ FOR

Auditor

Grant Thornton LLP

Tenure

N/A

Audit Fees

$954,000

Non-Audit Fees

$0

Grant Thornton billed $954,000 in audit fees for 2025 with zero non-audit fees, making the non-audit ratio 0% — well within the 50% threshold that would raise independence concerns. Auditor tenure is not disclosed in the proxy so the tenure trigger cannot fire per policy. No material restatements are disclosed. Grant Thornton is a large national firm appropriate for a $222M market-cap company.

Overall Assessment

Spok's 2026 annual meeting ballot presents four proposals: director elections, auditor ratification, Say on Pay, and an equity plan amendment. All three standard governance proposals pass policy screens cleanly — the director slate shows no overboarding or attendance issues and the company's stock has modestly outperformed the XLV healthcare ETF over three years, the auditor has zero non-audit fees, and CEO pay is structured with strong variable components at peer-median levels with 96% prior-year shareholder approval. The equity plan amendment falls outside current policy coverage and no determination is made on that item.

Filing date: April 30, 2026·Policy v1.2·high confidence